Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
331.13B | 332.59B | 303.92B | 338.57B | 344.05B | Gross Profit |
127.67B | 120.35B | 110.75B | 158.03B | 162.41B | EBIT |
11.06B | 18.52B | 12.85B | 19.31B | 18.52B | EBITDA |
29.06B | 34.05B | 27.93B | 35.09B | 34.36B | Net Income Common Stockholders |
8.11B | 14.13B | 8.10B | 13.52B | 11.84B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
60.24B | 97.20B | 91.93B | 102.25B | 98.64B | Total Assets |
377.77B | 395.74B | 369.05B | 356.74B | 340.08B | Total Debt |
165.00M | 30.00B | 30.02B | 30.35B | 30.64B | Net Debt |
-56.45B | -67.20B | -61.68B | -71.67B | -67.26B | Total Liabilities |
105.18B | 132.63B | 124.30B | 115.57B | 117.53B | Stockholders Equity |
272.00B | 262.54B | 244.29B | 240.79B | 221.75B |
Cash Flow | Free Cash Flow | |||
-15.66B | 9.69B | -8.89B | 4.89B | 474.00M | Operating Cash Flow |
1.81B | 28.06B | 16.80B | 28.65B | 17.22B | Investing Cash Flow |
-10.26B | -10.37B | -20.14B | -29.19B | -12.44B | Financing Cash Flow |
-39.15B | -6.09B | -10.28B | -4.86B | -9.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $7.83T | 43.64 | 4.55% | 4.06% | 10.98% | -63.74% | |
74 Outperform | ¥1.30T | 20.74 | 12.17% | 1.76% | 7.29% | 9.77% | |
74 Outperform | ¥378.00B | 17.52 | 10.34% | 1.90% | 7.15% | 8.57% | |
74 Outperform | ¥3.41T | 48.92 | 8.89% | 1.14% | 8.76% | -0.23% | |
64 Neutral | $8.78B | 14.55 | 4.78% | 173.91% | 3.39% | 2.17% | |
64 Neutral | $1.67T | 29.40 | 4.91% | 3.58% | 9.00% | -57.41% | |
55 Neutral | €293.74B | 52.90 | 2.04% | 1.97% | -3.24% | -63.77% |
Ezaki Glico Co., Ltd. announced the establishment of a special purpose company, Glico Europe B.V., in the Netherlands as part of its strategy to pursue global growth investments. This move aligns with the company’s mid-term management plan to expand its business into new areas and promote global growth, with a minor expected impact on the company’s earnings for the fiscal year ending December 31, 2025.